{"id":651431,"date":"2023-05-15T16:44:02","date_gmt":"2023-05-15T16:44:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=651431"},"modified":"2023-05-15T16:44:02","modified_gmt":"2023-05-15T16:44:02","slug":"biliary-atresia-market-to-exhibit-substantial-growth-rate-during-the-forecast-period-20232032-delveinsight-key-companies-mirium-pharmaceuticals-albireo-intercept-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/biliary-atresia-market-to-exhibit-substantial-growth-rate-during-the-forecast-period-20232032-delveinsight-key-companies-mirium-pharmaceuticals-albireo-intercept-pharmaceuticals_651431.html","title":{"rendered":"Biliary Atresia Market to Exhibit Substantial Growth Rate During the Forecast Period (2023-2032) – DelveInsight | Key Companies – Mirium Pharmaceuticals, Albireo, Intercept Pharmaceuticals"},"content":{"rendered":"
\n
\"Biliary<\/a><\/div>\n
\n
Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
As per DelveInsight, the Biliary Atresia Market is anticipated to evolve immensely in the coming years owing to the rise in the number of incident cases of Biliary Atresia patients in 7MM and the launch of new therapies in the market.<\/div>\n

DelveInsight’s “Biliary Atresia Market Insights, Epidemiology, and Market Forecast 2032<\/strong>” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Biliary Atresia market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).<\/p>\n

The Biliary Atresia market report covers emerging drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/p>\n

Biliary Atresia: An Overview<\/strong><\/p>\n

Biliary Atresia is a condition in infants in which the bile ducts—tubes inside and outside the liver—are scarred and blocked. Bile ducts carry bile from the liver to the gallbladder for storage, and to the first part of the small intestine, also called the duodenum, for use in digestion. In infants with Biliary Atresia, bile can’t flow into the intestine, so bile builds up in the liver and damages it. The damage leads to scarring, loss of liver tissue and function, and cirrhosis.<\/p>\n

There are two types of Biliary Atresia, a fetal form, which develops during fetal life and is present at birth, and a more common perinatal form, which does not become evident until the second to fourth week of the infant’s life.<\/p>\n

Biliary Atresia Market Key Facts<\/strong><\/p>\n